Skip to main content
Signal8

Nark Ted C

SEC insider (Form 3/4/5 filer). CIK 0001316851. Director at Amneal Pharmaceuticals, Inc. (AMRX). 5 reported Form 4/5 transactions since Sep 2024; latest on May 7, 2026. Located in BRIDGEWATER, NJ.

Companies Nark Ted C has filed insider reports for

  • Amneal Pharmaceuticals, Inc. (AMRX): Director
Nark Ted C profile photo

Nark Ted C

CIK: 0001316851

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Amneal Pharmaceuticals, Inc. logo
AMRX

Amneal Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 7, 2026
    Exercise
    Direct
    34.8K shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 6, 2026
    Award

    Restricted Stock Units

    Direct
    19.8K shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    Nov 17, 2025
    Sale
    Direct
    50K shares at avg. $11.72$586K
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 6, 2025
    Award

    Restricted Stock Units

    Direct
    34.8K shares-
  • Amneal Pharmaceuticals, Inc. logo
    AMRX

    Amneal Pharmaceuticals, Inc.

    May 5, 2025
    Exercise
    Direct
    40.3K shares-

1-5 of 5